Categories: Wall Street Journal

11/6/2017

WSJ’s look at stent study: Solid reporting, with room for more detail on costs and risks

10/27/2017

Plenty of context, but evidence was AWOL in WSJ story on uterine fibroid treatment

10/17/2017

WSJ wisely reports on Ebola vaccines: ‘It is unknown…what antibody levels are needed to protect patients’

6/28/2017

WSJ’s look at digital therapy covers a lot of ground–except potential downsides

4/26/2017

WSJ story on prostate procedure: No independent sources were quoted

2/21/2017

In story on vision-improving headset, WSJ left most important detail in the dark

11/30/2016

Thorough WSJ report on insomnia treatments would have benefited from cost comparison

11/11/2016

Fast-track treatment for hip fractures: WSJ story needed some figures to back up the claims

10/27/2016

WSJ story wisely includes lots of caveats on mail-order telomere tests

9/29/2016

WSJ story on new nuclear-imaging tests: What about the data?